Bupropion metabolites and methods of their synthesis and use

Details for Australian Patent Application No. 2000269268 (hide)

Owner Sepracor, Inc.

Inventors Grover, Paul; Senanayake, Chrisantha H.; Fang, Qun K.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2000269268

PCT Pub. Number WO01/62257

Priority 09/510,241 22.02.00 US; 09/640,725 18.08.00 US; 09640725 18.08.00 US; 09510241 22.02.00 US

Filing date 23 August 2000

Wipo publication date 8 July 2002

Acceptance publication date 8 September 2005

International Classifications

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61P 025/20 Drugs for disorders of the nervous system

A61P 025/34 Drugs for disorders of the nervous system

A61P 025/24 Drugs for disorders of the nervous system

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

8 September 2005 Application Accepted

  Published as AU-B-2000269268

6 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2000269277-Novel polymer compounds

2000269264-Treatment of trauma, and other indications